A 12 month study to compare the safety and efficacy of 2 doses of fingolimod every day vs. Copaxone 20mg SC every day for Relapsing Remitting MS.
- Ages 18-65
- Must have 1 documented relapse in the last year
- No varicella zoster
- No one with heart rate less than 45/bpm
- No uncontrolled diabetes
- No positive Hepatitis A, B, C and E